Abstract
Previous reports in European populations demonstrated the existence of five data-driven adult-onset diabetes subgroups. Here, we use self-normalizing neural networks (SNNN) to improve reproducibility of these data-driven diabetes subgroups in Mexican cohorts to extend its application to more diverse settings. We trained SNNN and compared it with k-means clustering to classify diabetes subgroups in a multiethnic and representative population-based National Health and Nutrition Examination Survey (NHANES) datasets with all available measures (training sample: NHANES-III, n=1132; validation sample: NHANES 1999-2006, n=626). SNNN models were then applied to four Mexican cohorts (SIGMA-UIEM, n=1521; Metabolic Syndrome cohort, n=6144; ENSANUT 2016, n=614 and CAIPaDi, n=1608) to characterize diabetes subgroups in Mexicans according to treatment response, risk for chronic complications and risk factors for the incidence of each subgroup. SNNN yielded four reproducible clinical profiles (obesity related, insulin deficient, insulin resistant, age related) in NHANES and Mexican cohorts even without C-peptide measurements. We observed in a population-based survey a high prevalence of the insulin-deficient form (41.25%, 95% CI 41.02% to 41....Continue Reading
References
Apr 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·P Z ZimmetD A Lang
Jul 5, 2003·The Journal of Clinical Endocrinology and Metabolism·Ele FerranniniRalph A DeFronzo
Nov 4, 2006·BMC Gastroenterology·Giorgio BedogniClaudio Tiribelli
May 31, 2007·The British Journal of Mathematical and Statistical Psychology·Douglas Steinley
Feb 13, 2013·BMC Bioinformatics·Paulo J G LisboaSimon J Chambers
Jan 7, 2014·Nature·Amy L WilliamsDavid Altshuler
Jun 20, 2015·Bioinformatics·Günter KlambauerSepp Hochreiter
Feb 13, 2016·Endocrine Research·Alessandro P DelitalaRoberto Manetti
Jan 5, 2017·Nutrition Reviews·Omar Y Bello-ChavollaMauricio Hernández-Avila
Mar 6, 2018·The Lancet. Diabetes & Endocrinology·Emma AhlqvistLeif Groop
Mar 15, 2018·European Journal of Endocrinology·Omar Yaxmehen Bello-ChavollaCarlos A Aguilar-Salinas
Mar 24, 2018·The Lancet. Diabetes & Endocrinology·William G HerringtonJonathan R Emberson
Sep 22, 2018·PLoS Medicine·Miriam S UdlerJose C Florez
Oct 12, 2018·Acta Diabetologica·Norma C Segovia-GamboaCarmen Sanchez-Torres
Nov 27, 2018·European Journal of Endocrinology·Paloma Almeda-ValdesCarlos A Aguilar-Salinas
Dec 24, 2018·The Lancet. Diabetes & Endocrinology·Xiantong ZouLinong Ji
Apr 8, 2019·Diabetes Research and Clinical Practice·Sergio Hernández-JiménezUNKNOWN Group of Study CAIPaDi
Apr 16, 2019·Frontiers in Endocrinology·Sriram GubbiFady Hannah-Shmouni
Apr 30, 2019·BMC Endocrine Disorders·Olimpia Arellano-CamposCarlos A Aguilar-Salinas
May 3, 2019·The Lancet. Diabetes & Endocrinology·John M DennisAndrew T Hattersley
May 8, 2019·Scientific Reports·Zeenat A ShyrMaria S Remedi
May 31, 2019·Current Obesity Reports·Uchenna AgbimSam Dagogo-Jack
Jul 28, 2019·The Lancet. Diabetes & Endocrinology·Oana P ZahariaUNKNOWN German Diabetes Study Group
Aug 12, 2019·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Omar Yaxmehen Bello-ChavollaCarlos A Aguilar-Salinas
Nov 11, 2019·Diabetes Research and Clinical Practice·Michael P BancksAlain G Bertoni
Dec 24, 2019·Salud pública de México·Ana Basto-AbreuSalvador Villalpando
Citations
Jan 31, 2021·BMJ Open Diabetes Research & Care·Rodrigo M Carrillo-LarcoAntonio Bernabé-Ortiz
Mar 25, 2021·Pharmacogenomics and Personalized Medicine·Ranjit UnnikrishnanViswanathan Mohan
Mar 18, 2021·The Journal of Clinical Endocrinology and Metabolism·Omar Yaxmehen Bello-ChavollaJessica Paola Bahena-López
Aug 25, 2021·Current Heart Failure Reports·Pishoy GoudaAbhinav Sharma
Oct 6, 2021·Diabetes Technology & Therapeutics·Ranjit Mohan AnjanaViswanathan Mohan
Nov 6, 2021·Nature Genetics·Dina Mansour AlyEmma Ahlqvist